Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and tolerability of subretinal delivery of Adeno-associated Virus Vector (AAV5 hRKp.RPGR) gene therapy in adults and children with X-linked retinitis ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Janssen Research & Development, LLC
NCT07174726 · X-Linked Retinitis Pigmentosa (XLRP)
NCT06492850 · X-Linked Retinitis Pigmentosa (XLRP)
NCT04850118 · X-Linked Retinitis Pigmentosa
NCT04517149 · X-Linked Retinitis Pigmentosa
NCT03314207 · X-Linked Retinitis Pigmentosa
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan
Moorfields Eye Hospital
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions